Adult & childnManagement of reversible airways obstruction, asthma, COPD Intermittent administration: 2.5-5 mL via nebuliser qid. Continuous administration: 0.005-0.01% via nebuliser at 1-2 mg/hr.
Do not administer via inj. Patients who received large doses of sympathomimetic drugs. Thyrotoxicosis. Acute severe asthma. Monitor serum K levels. Concomitant use w/ xanthine derivatives, steroids, diuretics & by hypoxia; ipratropium Br. Acute angle closure glaucoma. Avoid contact w/ eye. Pregnancy & lactation.
R03AC02 - salbutamol ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Sign Out
